Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Takes Out The Alzheimer’s Trash

Jan 22 2024

• By Elizabeth Cairns

Roche

Related Content

Roche Looks To Muscle Into Obesity Market With $2.7bn Carmot Buyout

Dec 04 2023

Anti-Tau For Alzheimer's In The Dock After Semorinemab Fail

Sep 24 2020

AC Immune/Roche Drop Crenezumab After Phase III CREAD Alzheimer's Failure

Jan 30 2019

Failure Of Roche’s Nine-Year Alzheimer’s Prevention Study Disappointing, But No Surprise

Jun 16 2022

Cautious Optimism As Genentech/AC Immune’s Anti-Tau Antibody Slows Cognitive Decline

Aug 31 2021

Roche Makes Play For Bowel Disease Leadership With $7.1bn Roivant Deal

Oct 23 2023

Related Companies

Roche Holding AG

AC Immune SA

Carmot Therapeutics Inc.

Roivant Sciences Ltd.

Additional Topics

Deals Companies Commercial Neurology BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window